The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
about
Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitorsPan-cancer analysis reveals technical artifacts in TCGA germline variant callsGermline Variants of Prostate Cancer in Japanese Families.Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.Response of BRCA1-mutated gallbladder cancer to olaparib: A case report.Is Low FMR1 CGG Repeat Length in Males Correlated with Family History of BRCA-Associated Cancers? An Exploratory Analysis of Medical Records.Single nucleotide polymorphisms in DNA repair genes and putative cancer risk.The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell linesIdentification of pleiotropic cancer susceptibility variants from genome-wide association studies reveals functional characteristics.BRCA1/2 Mutations in Salivary Pleomorphic Adenoma and Carcinoma-ex-Pleomorphic Adenoma.Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.Identification of a Rare Germline Heterozygous Deletion Involving the Polycistronic miR-17-92 Cluster in Two First-Degree Relatives from a BRCA 1/2 Negative Chilean Family with Familial Breast Cancer: Possible Functional Implications.Identification of bladder cancer prognostic biomarkers using an ageing gene-related competitive endogenous RNA network.Molecular Diagnostics in Clinical Oncology
P2860
Q28073470-96AE6C1C-1E3D-4BB2-8535-08BA841F3286Q33618910-2450594C-CEA4-46DF-B22C-72AA14E2F3A8Q33786614-F2520B51-766A-45B0-8CD8-600F009C1743Q36152825-0C147843-2449-48C1-B097-AA7D7C5D55E4Q37261018-A55C2AC7-6AD4-4E5D-8E8C-F258CDC8504BQ37501085-4C8B97B5-AABA-43AE-9582-A341AF217A3BQ38699063-0A5B3F90-FD9A-4B4D-B188-BD1395041918Q38873757-64AFA610-F37A-4696-A864-AD4678669308Q39190147-F06950C9-ADF5-4151-86C0-89BEF4926734Q40321595-E6BF8186-5BD6-4C72-B0F1-AE23DB82ADF9Q42292362-EC9C3CE0-E219-43DF-B7E6-57BCCFF750E1Q46020569-28543BDF-9D5C-4311-A0FB-73CEDB40B2B9Q47101613-7D064B23-5299-4A81-927D-31F8A4557717Q47761787-6A774D16-FAC3-46F7-BB5A-C03B5BD4E301Q48182576-B4C1B7B7-A13D-4BAB-A317-3EDBFF400309Q48534813-1815D7F2-630C-4943-A987-7A45CAB85946Q58700723-E806D038-BF5E-4C49-8702-72E9A6B35C72
P2860
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@ast
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@en
type
label
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@ast
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@en
prefLabel
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@ast
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@en
P2860
P1476
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
@en
P2093
Helen Cavanagh
Katherine M A Rogers
P2860
P2888
P356
10.1186/S13053-015-0038-X
P577
2015-08-01T00:00:00Z
P5875
P6179
1015885733